Dallas TX 心脏病临床试验
10项针对 心脏病的研究正在 Dallas及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
正在为研究招募参与者?将此页面置顶展示 — $99 / 30天 →
ELEVATE-HFpEF Clinical Study
招募中
- Dallas VA Medical Center, Dallas
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
招募中
- Texas Health Presbyterian Hospital Dallas, Dallas
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
招募中
- Baylor University Medical Center, part of Baylor Scott & White Health, Dallas
- UT southwestern Medical Center, Dallas
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
招募中3 期
- University of Texas Southwestern, Dallas
Cardiac Clearance vs G60 Hip Frailty Index
招募中观察性研究
- Clinical Research Institute at Methodist Health System, Dallas
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
招募中
- Medical City Healthcare Dallas, Dallas
- Baylor Scott & White -Dallas, Dallas
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
招募中
- Baylor University Hospital, Dallas
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
招募中
- Baylor Scott & White Research Institute, Dallas
South Asians and Coronary Plaque Registry
招募中观察性研究欢迎健康志愿者
- University of Texas Southwestern Medical Center, Dallas
PARTNER 3 Trial - Aortic Valve-in-Valve
招募中
- Medical City Dallas Hospital, Dallas
- The Heart Hospital Baylor Plano, Dallas
其他城市的 心脏病试验
- New York City, NY18 项研究
- Boston, MA14 项研究
- Cleveland, OH13 项研究
- Los Angeles, CA12 项研究
- Portland, OR11 项研究
- Philadelphia, PA11 项研究
- Atlanta, GA10 项研究
- Rochester, MN10 项研究
- Durham, NC10 项研究
- Washington, DC9 项研究
- Baltimore, MD9 项研究
- Phoenix, AZ9 项研究
Dallas的其他研究
- 乳腺癌55 项研究
- 非小细胞肺癌52 项研究
- 转移性癌症42 项研究
- 心力衰竭42 项研究
- 癌症(所有类型)37 项研究
- 前列腺癌36 项研究
- 结直肠癌33 项研究
- 肥胖症30 项研究
- 卵巢癌28 项研究
- 膀胱癌27 项研究
- 肺癌27 项研究
- 子宫内膜癌24 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月5日。每项研究自行设定入选标准,由研究团队决定谁能参与。